PFE - Pfizer Inc Stock Analysis
Pfizer Inc (PFE) is a publicly traded company listed on the NYSE. It operates in the Drug Manufacturers - General industry, part of the broader Healthcare sector. The company has a market capitalization of 145.84B, generates annual revenue of 62.78B, and reports net income of 9.80B. As of the latest data, the stock is trading at 25.65 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock provides a high dividend yield (6.66%), which could indicate strong income potential — or possible risk. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.55), indicating current market sentiment. Institutional ownership is reported at 66.74%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -2.17%, trading within a 52-week range of 20.92 - 27.69.
PFE - Pfizer Inc
25.65
Analyst Consensus
Hold 3.55
PFE – Analyst Rating Summary
- Strong Buy: 5
- Buy: 10
- Hold: 17
- Sell: 0
- Strong Sell: 1
- Total Analysts: 33
| Index: | S&P 500 | P/E: | 14.95 | EPS (ttm): | 1.72 | Insider Own: | 0.09% | Shs Outstand: | 5.69B | Perf Week: | 0.67% |
| Market Cap: | 145.84B | Forward P/E: | 8.59 | EPS next Y: | 2.99 | Insider Trans: | 0.00% | Shs Float: | 5.68B | Perf Month: | 0.47% |
| Income(ttm): | 9.80B | PEG: | - | EPS next Q: | 0.58 | Inst Own: | 66.74% | Short Float: | 2.29% | Perf Quarter: | 5.86% |
| Revenue(ttm): | 62.78B | P/S: | 2.32 | EPS this Y: | 0.49% | Inst Trans: | -0.50% | Short Ratio: | 2.06 | Perf Half Y: | 4.82% |
| Book/sh: | 16.32 | P/B: | 1.57 | EPS next Y: | -4.43% | ROA: | 4.58% | Short Interest: | 130.02M | Perf Year: | -2.17% |
| Cash/sh: | 2.64 | P/C: | 9.73 | EPS next 5Y: | -2.61% | ROE: | 10.59% | 52W Range: | 20.92 - 27.69 | Perf YTD: | 3.01% |
| Dividend Est.: | 1.71 (6.66%) | P/FCF: | 14.06 | EPS past 3/5Y: | -28.69% -13.27% | ROIC: | 6.52% | 52W High: | 27.69 -7.37% | Beta: | 0.43 |
| Dividend TTM: | 1.72 (6.71%) | Quick Ratio: | 0.97 | Sales past 3/5Y: | -7.84% 9.10% | Gross Margin: | 69.12% | 52W Low: | 20.92 22.64% | Perf 5Y: | -32.09% |
| Dividend Ex-Date: | Jan 23, 2026 | Current Ratio: | 1.28 | EPS Y/Y TTM: | 128.96% | Oper. Margin: | 30.99% | RSI (14): | 55.28 | Volatility: | 2.05% 1.65% |
| Employees: | 81000 | Debt/Eq: | 0.66 | Sales Y/Y TTM: | 4.44% | Profit Margin: | 15.60% | Recom: | 2.39 | Target Price: | 28.51 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.62 | EPS Q/Q: | -20.96% | Payout: | 120.11% | Rel Volume: | 0.92 | Prev Close: | 25.89 |
| Sales Surprise: | 0.94% | EPS Surprise: | 37.53% | Sales Q/Q: | -5.92% | Earnings: | Feb 03 BMO | Avg Volume: | 63.27M | Price: | 25.65 |
| SMA20: | 1.64% | SMA50: | 1.33% | SMA200: | 4.82% | Undervalued: 11.15% | Volume: | 58,107,675 | Change: | -0.93% | |
Graham Classic formula value: 5.07
(P/E=8 * 1g) Min value: 8.32
(current P/E * 2g) Max value: 15.03
Average value: 9.47
About Pfizer Inc
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.